GlassScriptPhysician profile
Rashida A Abbas
NPI 1811044605
$3,613.09
in general payments reported to CMS, 2019-2025
14 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $40.26 · 2021: $1,310 · 2022: $120 · 2023: $125 · 2024: $236 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Travel and Lodging: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.74 |
| Travel and Lodging | $737.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,304.28 | 2021-2025 | Triclip, Mitraclip, Gallant |
| Edwards Lifesciences Corporation | $1,214.05 | 2021-2022 | |
| Boston Scientific Corporation | $268.83 | 2020-2025 | Watchman Access System, Resonate El Icd Vr, Watchman Flx |
| Janssen Pharmaceuticals, INC | $251.67 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $203.90 | 2019-2025 | |
| Pfizer INC. | $107.87 | 2020-2024 | |
| Amgen INC. | $91.91 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.62 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $38.53 | 2023-2025 | Camzyos |
| Abiomed | $25.84 | 2025 | |
| Siemens Medical Solutions USA, INC. | $18.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.09 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.14 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashida Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.